CC ligand 2 levels are increased in LPS-stimulated peripheral monocytes of patients with non-small cell lung cancer

In conclusion, after LPS stimulation, PBMCs of patients with NSCLC release higher levels of CCL2 as compared to those of non-smokers, supporting the hypothesis of a CCL2 involvement in NSCLC biology.